Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance (NCT05796375)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this research is to determine whether bladder cancer monitoring can be improved by replacing some cystoscopy procedures with urine testing. Specifically, this study examines whether there are any differences in urinary symptoms, discomfort, number of invasive procedures, anxiety, complications, cancer recurrence or cancer progression when some cystoscopy procedures are replaced with urine testing.
Who can join: Review the eligibility criteria below.
Location: West Haven VA Medical Center — West Haven, Connecticut
Age range: 18 Years
🧪 Interventions in This Study
- Cystoscopy (PROCEDURE)
- Bladder EpiCheck urine test (DIAGNOSTIC_TEST)
- Xpert Bladder Cancer Monitor urine test (DIAGNOSTIC_TEST)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (10 Sites)
- West Haven VA Medical Center — West Haven, Connecticut
- Bay Pines VA Healthcare System — Bay Pines, Florida
- James A. Haley Veterans' Hospital — Tampa, Florida
- VA Boston Jamaica Plains Campus — West Roxbury, Massachusetts
- VA St.Louis Healthcare System — St Louis, Missouri
- Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire
- University Hospitals Cleveland Medical Center — Cleveland, Ohio
- Medical University of South Carolina — Charleston, South Carolina
- UT Southwestern Medical Center — Dallas, Texas
- White River Junction Veterans Healthcare System — White River Junction, Vermont
📞 Contact the Study Coordinator
Phone: (802) 295-9363
Email: Prabhavath.Loganathan@va.gov
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Non-muscle-invasive Bladder Cancer
- Intravesical BCG vs GEMDOCE in NMIBC — Birmingham, Alabama
- Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer — Auchenflower,
- A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer — Little Rock, Arkansas
- Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC) — Dallas, Texas
- A Phase I Intravesical PPM Therapy for NMIBC — Boston, Massachusetts
Explore by condition: All Non-muscle-invasive Bladder Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.